Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IoM finds no thimerosal link to autism

Executive Summary

Neither the measles-mumps-rubella vaccine nor thimerosal-containing vaccines are associated with autism, a May 17 Institute of Medicine report says. The 1report, "Immunization Safety Review: Vaccines and Autism," updates a 2001 report that found the link between thimerosal and neurodevelopmental disorders was unclear (2"The Pink Sheet" Oct. 8, 2001, p. 11). The latest report is based on "overwhelming evidence from several well-designed" clinical and epidemiological studies...
Advertisement

Related Content

Vaccine Safety Body Proposed To Remove FDA “Conflict Of Interest”
Thimerosal-Free Flu Vaccine Design Being Discussed By FDA, Manufacturers
Thimerosal-Free Flu Vaccine Design Being Discussed By FDA, Manufacturers
Advertisement
UsernamePublicRestriction

Register

PS044029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel